How Nurses Can Support Physicians in Identifying Colorectal Cancer Risk

Video

Ascertaining family history and promoting screening are key.

Nurses can support providers in identifying patients’ colorectal cancer risk by enabling them with the tools and information needed to assess it.

“Colorectal cancer is the most preventable solid tumor on the planet,” says Thomas Weber, MD, FACS, founder and president of the Colon Cancer Foundation.

In this video, Weber explains how nurses can focus on ascertaining patients’ family history and ensuring that patients get their colonoscopies when they are due.

Newsletter

Stay up to date on recent advances in oncology nursing and patient care.

Subscribe Now!
Recent Videos
Photo of a woman with brown hair and bangs, surrounded by a blue border
Photo of an open bottle of pills
4 experts in this video
4 experts in this video
Photo of a woman wearing a blazer and a colorful scarf in front of a blue background
Related Content
Graphic of a person's gastrointestinal tract.

Retifanlimab Lengthens Survival for Patients With Anal Cancer

Sabrina Serani
August 2nd 2025
Article

The addition of retifanlimab to chemotherapy increased progression-free survival in patients with advanced squamous cell carcinoma of the anal canal.

The Vitals

ctDNA Monitoring is a Piece of the Puzzle in CRC Treatment

Lindsay Fischer
August 2nd 2025
Podcast

Holly Chitwood, DNP, FNP-C, AGACNP-BC, explains how circulating tumor DNA monitoring helps providers screen minimal residual disease in individuals with colorectal cancer.

Graphic of a person's esophagus and stomach

Zanidatamab/Chemo Yields Durable Response in HER2+ Gastroesophageal Cancer

Russ Conroy
August 2nd 2025
Article

Further data could back zanidatamab as advanced treatment for HER2-positive advanced gastroesophageal adenocarcinoma.

The Vitals

Terri Pollack Offers Perspective on 2023 ASCO GI Cancers Symposium

Lindsay Fischer
August 2nd 2025
Podcast

In this episode of "The Vitals," Terri Pollack, DNP, APRN, FNP-C, PMHNP-BC, underscores potentially practice-changing data which were presented during the 2023 GI Cancers Symposium.

Anatomical image of a pancreas with tumors

Atebimetinib Combo Shows Survival Signal in First-Line Pancreatic Cancer

Chris Ryan
August 2nd 2025
Article

The novel MEK inhibitor atebimetinib plus chemotherapy showed early signs of survival benefit in first-line treatment of patients with pancreatic cancer.

Illustration of a pancreas on a blue background

Novel ADC Receives FDA Fast Track Designation for Pancreatic Cancer

Sabrina Serani
August 2nd 2025
Article

The novel antibody-drug conjugate EBC-129 has been fast tracked by the FDA for approval in pancreatic ductal adenocarcinoma.